330 related articles for article (PubMed ID: 15047802)
1. Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis.
Haijema BJ; Volders H; Rottier PJ
J Virol; 2004 Apr; 78(8):3863-71. PubMed ID: 15047802
[TBL] [Abstract][Full Text] [Related]
2. Establishment of Full-Length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.
Wang G; Hu G; Liang R; Shi J; Qiu X; Yang Y; Jiao Z; Chen Y; Shen Z; Li M; Shi Y; Mao J; Peng G
J Virol; 2021 Oct; 95(21):e0074521. PubMed ID: 34406859
[TBL] [Abstract][Full Text] [Related]
3. Protection of cats from infectious peritonitis by vaccination with a recombinant raccoon poxvirus expressing the nucleocapsid gene of feline infectious peritonitis virus.
Wasmoen TL; Kadakia NP; Unfer RC; Fickbohm BL; Cook CP; Chu HJ; Acree WM
Adv Exp Med Biol; 1995; 380():221-8. PubMed ID: 8830483
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus.
Glansbeek HL; Haagmans BL; Te Lintelo EG; Egberink HF; Duquesne V; Aubert A; Horzinek MC; Rottier PJM
J Gen Virol; 2002 Jan; 83(Pt 1):1-10. PubMed ID: 11752695
[TBL] [Abstract][Full Text] [Related]
5. Immunization of cats against feline infectious peritonitis with anti-idiotypic antibodies.
Escobar JC; Kochik SA; Skaletsky E; Rosenberg JS; Beardsley TR
Viral Immunol; 1992; 5(1):71-9. PubMed ID: 1319173
[TBL] [Abstract][Full Text] [Related]
6. Reverse Genetics for Type I Feline Coronavirus Field Isolate To Study the Molecular Pathogenesis of Feline Infectious Peritonitis.
Ehmann R; Kristen-Burmann C; Bank-Wolf B; König M; Herden C; Hain T; Thiel HJ; Ziebuhr J; Tekes G
mBio; 2018 Jul; 9(4):. PubMed ID: 30065095
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a Virulent Full-Length cDNA Clone for Type I Feline Coronavirus Strain C3663.
Terada Y; Kuroda Y; Morikawa S; Matsuura Y; Maeda K; Kamitani W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375588
[TBL] [Abstract][Full Text] [Related]
8. Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP.
Hohdatsu T; Yamato H; Ohkawa T; Kaneko M; Motokawa K; Kusuhara H; Kaneshima T; Arai S; Koyama H
Vet Microbiol; 2003 Dec; 97(1-2):31-44. PubMed ID: 14637036
[TBL] [Abstract][Full Text] [Related]
9. The influence of age and genetics on natural resistance to experimentally induced feline infectious peritonitis.
Pedersen NC; Liu H; Gandolfi B; Lyons LA
Vet Immunol Immunopathol; 2014 Nov; 162(1-2):33-40. PubMed ID: 25265870
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibody-dependent enhancement infection of cats with type I FIPV via the oral route.
Takano T; Yamada S; Doki T; Hohdatsu T
J Vet Med Sci; 2019 Jun; 81(6):911-915. PubMed ID: 31019150
[TBL] [Abstract][Full Text] [Related]
11. Characterization of antiviral T cell responses during primary and secondary challenge of laboratory cats with feline infectious peritonitis virus (FIPV).
Mustaffa-Kamal F; Liu H; Pedersen NC; Sparger EE
BMC Vet Res; 2019 May; 15(1):165. PubMed ID: 31118053
[TBL] [Abstract][Full Text] [Related]
12. A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination.
Olsen CW
Vet Microbiol; 1993 Jul; 36(1-2):1-37. PubMed ID: 8236772
[TBL] [Abstract][Full Text] [Related]
13. Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions.
Fehr D; Holznagel E; Bolla S; Hauser B; Herrewegh AA; Horzinek MC; Lutz H
Vaccine; 1997 Jul; 15(10):1101-9. PubMed ID: 9269053
[TBL] [Abstract][Full Text] [Related]
14. Disease outcome and cytokine responses in cats immunized with an avirulent feline infectious peritonitis virus (FIPV)-UCD1 and challenge-exposed with virulent FIPV-UCD8.
Kiss I; Poland AM; Pedersen NC
J Feline Med Surg; 2004 Apr; 6(2):89-97. PubMed ID: 15123153
[TBL] [Abstract][Full Text] [Related]
15. Feline Coronavirus 3c Protein: A Candidate for a Virulence Marker?
Hora AS; Tonietti PO; Taniwaki SA; Asano KM; Maiorka P; Richtzenhain LJ; Brandão PE
Biomed Res Int; 2016; 2016():8560691. PubMed ID: 27243037
[TBL] [Abstract][Full Text] [Related]
16. Switching species tropism: an effective way to manipulate the feline coronavirus genome.
Haijema BJ; Volders H; Rottier PJ
J Virol; 2003 Apr; 77(8):4528-38. PubMed ID: 12663759
[TBL] [Abstract][Full Text] [Related]
17. Feline Coronaviruses: Pathogenesis of Feline Infectious Peritonitis.
Tekes G; Thiel HJ
Adv Virus Res; 2016; 96():193-218. PubMed ID: 27712624
[TBL] [Abstract][Full Text] [Related]
18. The role of accessory proteins in the replication of feline infectious peritonitis virus in peripheral blood monocytes.
Dedeurwaerder A; Desmarets LM; Olyslaegers DAJ; Vermeulen BL; Dewerchin HL; Nauwynck HJ
Vet Microbiol; 2013 Mar; 162(2-4):447-455. PubMed ID: 23182908
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats.
Takano T; Tomizawa K; Morioka H; Doki T; Hohdatsu T
Antivir Ther; 2014; 19(7):645-50. PubMed ID: 24458025
[TBL] [Abstract][Full Text] [Related]
20. Recombinant feline coronaviruses as vaccine candidates confer protection in SPF but not in conventional cats.
Bálint Á; Farsang A; Szeredi L; Zádori Z; Belák S
Vet Microbiol; 2014 Mar; 169(3-4):154-62. PubMed ID: 24513277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
